World's Best Scientists 2026 revealed!
Frédéric Triebel

Frédéric Triebel

D-Index & Metrics

Immunology

D-Index
67
Citations
14276
World Ranking
2690
National Ranking
113

Frédéric Triebel publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Frédéric Triebel sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 181 publications — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Frédéric Triebel D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Frédéric Triebel sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 67 D-Index — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Frédéric Triebel is affiliated with the University of Paris-Saclay in France and has contributed extensively to the fields of medicine and immunology. Their research primarily focuses on oncology, immunology, and pulmonary and respiratory medicine, with significant work intersecting multiple subfields such as surgery and radiology.

The scientist's work covers core topics including cancer immunotherapy and biomarkers, immunotherapy and immune responses, colorectal and anal carcinomas, lung cancer treatments and mutations, ferroptosis and cancer prognosis, CAR-T cell therapy research, and immune cell function and interaction.

Frequent coauthors collaborating with Frédéric Triebel include Martin Förster, Julio A. Peguero, Matthew Krebs, Christian Mueller, and Margarita Majem. These collaborations have contributed to a wide range of publications in prominent journals.

They have published numerous articles in leading venues, with the most frequent being:

  • Journal of Clinical Oncology
  • Annals of Oncology
  • Regular and Young Investigator Award Abstracts
  • Cancer Research
  • Clinical Cancer Research

Key recent publications illustrating their research interests are:

  • "Eftilagimod alpha, a soluble lymphocyte activation gene-3 (LAG-3) protein plus pembrolizumab in patients with metastatic melanoma" (2020, Journal for ImmunoTherapy of Cancer)
  • "A LAG-3-Specific Agonist Antibody for the Treatment of T Cell-Induced Autoimmune Diseases" (2020, The Journal of Immunology)
  • "Molecular characterization of HLA class II binding to the LAG-3 T cell co-inhibitory receptor" (2020, European Journal of Immunology)
  • "A phase II study (TACTI-002) in first-line metastatic non-small cell lung carcinoma investigating eftilagimod alpha (soluble LAG-3 protein) and pembrolizumab: Updated results from a PD-L1 unselected population." (2022, Journal of Clinical Oncology)
  • "Initial results from a phase II study (TACTI-002) in metastatic non-small cell lung or head and neck carcinoma patients receiving eftilagimod alpha (soluble LAG-3 protein) and pembrolizumab." (2020, Journal of Clinical Oncology)

Frédéric Triebel's scholarly output spans 79 publications primarily in medicine and 18 in immunology and microbiology, aligning with their focus on immune response mechanisms in oncology contexts. The range of topics and frequent publication venues indicate an active involvement in advancing understanding and treatment options related to cancer immunotherapy and related immune pathways.

Best Publications

  • LAG-3, a novel lymphocyte activation gene closely related to CD4.

    F Triebel;S Jitsukawa;E Baixeras;S Roman-Roman

  • Orchestration and Prognostic Significance of Immune Checkpoints in the Microenvironment of Primary and Metastatic Renal Cell Cancer

    Nicolas Giraldo;Nicolas Giraldo;Nicolas Giraldo;Etienne Becht;Etienne Becht;Etienne Becht;Franck Pages;Georgios P Skliris

  • CD4/major histocompatibility complex class II interaction analyzed with CD4‐ and lymphocyte activation gene‐3 (LAG‐3)‐Ig fusion proteins

    Bertrand Huard;Philippe Prigent;Muriel Tournier;Denis Bruniquel

  • Characterization of the lymphocyte activation gene 3-encoded protein. A new ligand for human leukocyte antigen class II antigens.

    E Baixeras;B Huard;C Miossec;S Jitsukawa

  • Characterization of the major histocompatibility complex class II binding site on LAG-3 protein.

    Bertrand Huard;Renato Mastrangeli;Philippe Prigent;Denis Bruniquel

  • LAG-3 expression defines a subset of CD4(+)CD25(high)Foxp3(+) regulatory T cells that are expanded at tumor sites.

    Chiara Camisaschi;Chiara Casati;Francesca Rini;Michela Perego

  • Lymphocyte-activation gene 3/major histocompatibility complex class II interaction modulates the antigenic response of CD4+ T lymphocytes

    Bertrand Huard;Muriel Tournier;Thierry Hercend;Frédéric Triebel

  • First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity

    Chrystelle Brignone;Maya Gutierrez;Fawzia Mefti;Etienne Brain

  • A Phase I Pharmacokinetic and Biological Correlative Study of IMP321, a Novel MHC Class II Agonist, in Patients with Advanced Renal Cell Carcinoma

    Chrystelle Brignone;Bernard Escudier;Caroline Grygar;Manon Marcu

  • MHC Class II Engagement by Its Ligand LAG-3 (CD223) Contributes to Melanoma Resistance to Apoptosis

    Patrice Hemon;Francette Jean-Louis;Kiran Ramgolam;Chrystelle Brignone

  • CD3/TCR Complex-Associated Lymphocyte Activation Gene-3 Molecules Inhibit CD3/TCR Signaling

    Sigrid Hannier;Muriel Tournier;Georges Bismuth;Frédéric Triebel

  • The negative regulatory function of the lymphocyte-activation gene-3 co-receptor (CD223) on human T cells

    Laëtitia Maçon-Lemaître;Frédéric Triebel

  • Cellular expression and tissue distribution of the human LAG-3-encoded protein, an MHC class II ligand.

    B. Huard;P. Gaulard;F. Faure;T. Hercend

  • Maturation and activation of dendritic cells induced by lymphocyte activation gene-3 (CD223).

    Susanne Andreae;Fabienne Piras;Nicolas Burdin;Frédéric Triebel

  • A gamma-chain complex forms a functional receptor on cloned human lymphocytes with natural killer-like activity.

    P. Moingeon;S. Jitsukawa;F. Faure;F. Troalen

  • Identification of a human CD8+ regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4.

    Simone A. Joosten;Krista E. van Meijgaarden;Nigel D. L. Savage;Tjitske de Boer

  • LAG-3: a regulator of T-cell and DC responses and its use in therapeutic vaccination

    Frédéric Triebel

  • Direct evidence to support the immunosurveillance concept in a human regressive melanoma.

    A Mackensen;G Carcelain;S Viel;M C Raynal

  • MHC class II signal transduction in human dendritic cells induced by a natural ligand, the LAG-3 protein (CD223).

    Susanne Andreae;Sandrine Buisson;Frédéric Triebel

  • A unique V-J-C-rearranged gene encodes a gamma protein expressed on the majority of CD3+ T cell receptor-alpha/beta- circulating lymphocytes.

    Frederic Triebel;Florence Faure;Marita Graziani;Setsuko Jitsukawa

Frequent Co-Authors

Thierry Hercend
Thierry Hercend University of Nantes
Bernard Escudier
Bernard Escudier Institut Gustave Roussy
Sergio Roman-Roman
Sergio Roman-Roman Institute Curie
Anne Caignard
Anne Caignard Grenoble Alpes University
Luc Dirix
Luc Dirix GZA Ziekenhuizen Campus Sint-Augustinus
Chiara Castelli
Chiara Castelli University of Milan
Dominique Charron
Dominique Charron Grenoble Alpes University
Licia Rivoltini
Licia Rivoltini Fondazione IRCCS Istituto Nazionale dei Tumori
Jagadeesh Bayry
Jagadeesh Bayry Indian Institute of Technology Palakkad
Enriqueta Felip
Enriqueta Felip Vall d'Hebron Institut de Recerca

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can broaden career options. Nursing-related programs often provide practical pathways into clinical roles that complement immunology expertise. For example, many students seek out the easiest lpn programs to get into as a starting point for a nursing career, offering rapid entry into healthcare with foundational skills.

Advancing beyond LPN, there are nurse practitioner programs with easy admission that make it simpler to specialize and increase responsibilities. These programs often focus on versatile clinical skills applicable across multiple disciplines, including immunology-related fields.

For those drawn to mental health and immunology intersections, online options like the top psychiatric mental health nurse practitioner programs online offer excellent clinical placement rates. These programs train specialists to manage psychiatric conditions that may involve immune system factors.

Lastly, cost-effective learning is key for many. The cheap psych np programs provide affordable pathways to becoming a psychiatric nurse practitioner, allowing students to gain relevant credentials without excessive financial burden.

Best Scientists Citing Frédéric Triebel

Trending Scientists

Recently Published Articles